We found that GPX3 inhibits oxidative stress-related pathways (NFB pathway) and apoptosis-related pathways (Caspase pathway) (Figure 3B), which is consistent with our previous results
To access the behaviors outside the habit horizon we must expand motivation and self-efficacy, so the circle itself gets wider
So not only can you mess with the reward center in the brain, because this medication can do that, youre also [potentially] stimulating the response of, Dont come at me with any food. Or, in my case, perfume
Research reference: dosage ranges used in studies Scientific literature evaluating IGF-1 LR3 has explored a range of quantities and administration schedules depending on research objectives related to muscle hypertrophy, recovery, endurance, and metabolic health
These conditions may increase risk when using GLP-1 medications
When the body is at a lower weight, and you are no longer on the medication, your brain and body prioritize storing fat and see the decrease in calories as a sign of distress, which can mean you may still gain weight even if you continue habits you began while on medication, such as eating smaller portions